动物生长促进剂及性能增强剂市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

2024 年全球动物生长促进剂和性能增强剂市场价值为 163 亿美元，预计到 2034 年将以 6.3% 的复合年增长率增长，达到 298 亿美元，这得益于发展中国家强劲的发展势头。这些地区的快速城市化、可支配收入的增加以及不断变化的饮食偏好正在推动动物性蛋白质消费量的增加。随着全球粮食系统面临提高畜牧业生产力、效率和永续性的越来越大的压力，这个市场变得越来越重要。随着全球人口的增长和对高品质蛋白质需求的不断增长，对有效动物生长促进剂的需求从未如此强烈。商业畜牧业生产的集约化，尤其是在亚太地区和拉丁美洲，凸显了对可扩展、经济高效的解决方案的需求。此外，饲料科学的进步、动物福利意识的提高以及更严格的监管框架正在重塑产品开发策略。消费者和生产者都在寻求多功能解决方案，不仅可以提高生长率，还可以改善免疫功能、营养吸收和整体动物福祉，推动抗生素和非抗生素产品领域的创新。

在亚太地区，大规模商业畜牧养殖正在迅速扩张，以满足日益增长的国内需求，这对区域市场动态产生了重大影响。中国、印度和越南等国家的蛋白质消费量激增，推动了对先进饲料技术和性能增强型产品的投资。随着消费者期望的不断变化以及政府对食品安全与食品安全的重视，市场参与者纷纷推出综合饲料添加剂，以在不损害动物健康和合规性的前提下提高生产效率。

最强劲的成长催化剂之一仍然是全球对动物性蛋白质日益增长的需求，这促使食品生产商提高营运效率。因此，畜牧养殖户越来越多地将促生长添加剂纳入其饲料策略。如今的现代农业实践优先考虑高产量和成本效益，这为能够改善增重、增强免疫力和维持畜群健康的增效剂创造了巨大的市场，尤其是在高产量、集约化养殖系统中。这些添加剂不再被视为可有可无的工具，而是在控製成本的同时实现产量最大化的必要投入。

2024年，抗生素和非抗生素产品市场规模达48亿美元，预计2025年至2034年的复合年增长率为6%。长期以来，抗生素一直被用于促进增重和控制疾病风险，尤其是在工业化畜牧业。然而，全球对抗生素抗药性日益增长的担忧，加上监管准则的日益严格，正在加速向非抗生素替代品的转变。产业领导者正在投资益生菌、益生元、酵素和植物性物质等先进解决方案，以在符合全球食品安全标准的同时，提供类似的性能优势。消费者意识的增强以及对动物产品供应链透明度的需求也推动了这一转变。

2024年，家禽业占据动物生长促进剂和性能增强剂市场的最大份额，产值达74亿美元，预计到2034年将以6.7%的复合年增长率增长，占据整个市场的45.4%。受全球对鸡肉和鸡蛋等价格实惠的瘦肉蛋白的强劲需求推动，该领域持续强劲扩张。家禽生产者高度依赖饲料增效剂来降低死亡率并提高产量，尤其是在全球生产週期较短、文化消费障碍相对较低的情况下。这些因素使家禽养殖成为饲料性能技术创新的重点领域。

美国动物生长促进剂和性能增强剂市场在2024年创收37亿美元，预计2034年将以6.1%的复合年增长率成长。国内对肉类和乳製品的旺盛需求，正鼓励企业加大对饲料效率解决方案的投资。美国生产商也在适应不断变化的药物和非药物饲料添加剂监管法规，这促使其转向更永续、更注重合规的做法。随着对动物福利和消费者安全的重视，美国市场正成为非抗生素生长解决方案研发和产品开发的中心。

全球动物生长促进剂和性能增强剂市场的主要公司包括Bioniche Animal Health、帝斯曼、勃林格殷格翰、拜耳动物保健、默克动物保健、嘉吉公司、硕腾公司、百奥明控股有限公司、保宝动物保健和礼来动物保健公司。这些市场领导者正在加大研发投入，以开发安全、有效且符合法规要求的替代方案。他们的策略包括透过植物基和益生菌成分实现产品组合多元化、与饲料製造商建立合作伙伴关係，以及拓展新兴市场的业务，以利用区域成长潜力。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

• 产业生态系统分析
  • 影响价值链的因素
  • 利润率分析
  • 中断
  • 未来展望
  • 製造商
  • 经销商
• 川普政府关税
  • 对贸易的影响
    • 贸易量中断
    • 报復措施
  • 对产业的影响
    • 供应方影响（原料）
      • 主要材料价格波动
      • 供应链重组
      • 生产成本影响
  • 需求面影响（销售价格）
    • 价格传导至终端市场
    • 市占率动态
    • 消费者反应模式
  • 受影响的主要公司
  • 策略产业反应
    • 供应链重组
    • 定价和产品策略
    • 政策参与
  • 展望与未来考虑
• 贸易统计（HS编码）
  • 2021-2024年主要出口国
  • 2021-2024年主要进口国

註：以上贸易统计仅针对重点国家。

• 供应商格局
• 利润率分析
• 重要新闻和倡议
• 监管格局
• 衝击力
  • 成长动力
    • 全球对动物性蛋白质的需求不断增长
    • 畜牧养殖集约化
    • 动物营养和饲料添加剂的进展
    • 新兴市场商业畜牧业生产的扩张
  • 产业陷阱与挑战
    • 对抗生素类生长促进剂的监管限制
    • 消费者对有机和无抗生素肉的偏好日益增长
• 成长潜力分析
• 波特的分析
• PESTEL分析

第四章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第五章：市场估计与预测：依产品，2021 - 2034 年

• 主要趋势
• 抗生素和非抗生素
• 益生菌和益生元
• 有机酸
• 植物源性
• 饲料酵素
• 荷尔蒙
• 其他的

第六章：市场估计与预测：依动物类型，2021 - 2034 年

• 主要趋势
• 家禽
• 猪
• 家畜
• 水生动物
• 其他动物

第七章：市场估计与预测：按地区，2021 - 2034 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• MEA
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第八章：公司简介

• Bayer Animal Health
• Biomin Holding GmbH
• Bioniche Animal Health
• Boehringer Ingelheim
• Bupo Animal Health
• Cargill Inc.
• DSM
• Elanco Animal Health Incorporated
• Merck Animal Health
• Zoetis Inc.

The Global Animal Growth Promoters and Performance Enhancers Market was valued at USD 16.3 billion in 2024 and is estimated to grow at a CAGR of 6.3% to reach USD 29.8 billion by 2034, driven by strong momentum across developing regions where rapid urbanization, rising disposable incomes, and evolving dietary preferences are fueling higher consumption of animal-based proteins. This market is becoming increasingly vital as global food systems face mounting pressure to improve livestock productivity, efficiency, and sustainability. With an expanding global population and a rising appetite for high-quality protein, the demand for effective animal growth promoters has never been more pronounced. The intensification of commercial livestock production, particularly in Asia Pacific and Latin America, underscores the need for scalable, cost-effective solutions. Furthermore, advances in feed science, increased awareness around animal welfare, and stricter regulatory frameworks are reshaping product development strategies. Consumers and producers alike are seeking multifunctional solutions that not only enhance growth rates but also contribute to improved immune function, nutrient absorption, and overall animal well-being-driving innovation in both antibiotic and non-antibiotic product segments.

In Asia Pacific, large-scale commercial livestock operations are rapidly expanding to meet growing domestic demand, significantly impacting regional market dynamics. Countries like China, India, and Vietnam are witnessing a surge in protein consumption, propelling investment into advanced feed technologies and performance-enhancing products. With evolving consumer expectations and governmental emphasis on food security and safety, market players are responding with integrated feed additives that deliver productivity gains without compromising health or regulatory compliance.

One of the strongest growth catalysts remains the rising global demand for animal-derived proteins, which is pushing food producers to improve operational efficiency. As a result, livestock farmers are increasingly incorporating growth-promoting additives into their feed strategies. Today's modern farming practices prioritize high yield and cost-effectiveness, creating a significant market for performance enhancers that improve weight gain, fortify immune response, and maintain herd health-especially in high-volume, intensive farming systems. These additives are no longer seen as optional tools but as essential inputs to maximize output while controlling overhead.

In 2024, the antibiotic and non-antibiotic product segment accounted for USD 4.8 billion, with forecasts predicting a CAGR of 6% from 2025 to 2034. Antibiotics have long been utilized to promote weight gain and manage disease risks, particularly in industrial livestock operations. However, the increasing global concern over antimicrobial resistance, coupled with stricter regulatory guidelines, is accelerating a shift toward non-antibiotic alternatives. Industry leaders are investing in advanced solutions such as probiotics, prebiotics, enzymes, and phytogenics to deliver similar performance benefits while aligning with global food safety standards. This transition is also supported by heightened consumer awareness and a demand for transparency in animal product supply chains.

The poultry sector held the largest share of the animal growth promoters and performance enhancers market in 2024, generating USD 7.4 billion and projected to grow at a CAGR of 6.7% through 2034, capturing 45.4% of the total market. Driven by strong global demand for affordable, lean protein like chicken meat and eggs, this segment continues to experience robust expansion. Poultry producers rely heavily on feed efficiency enhancers to reduce mortality and improve output, especially given the shorter production cycles and relatively low cultural consumption barriers worldwide. These factors make poultry farming a key focus area for innovation in feed performance technology.

The United States Animal Growth Promoters and Performance Enhancers Market generated USD 3.7 billion in 2024 and is expected to grow at a CAGR of 6.1% through 2034. A high domestic demand for meat and dairy products is encouraging greater investment in feed efficiency solutions. U.S. producers are also adapting to evolving regulations that govern both medicated and non-medicated feed additives, prompting a shift toward more sustainable, compliance-focused practices. With an emphasis on animal welfare and consumer safety, the U.S. market is emerging as a hub for R&D and product development in non-antibiotic growth solutions.

Major companies operating in the global animal growth promoters and performance enhancers market include Bioniche Animal Health, DSM, Boehringer Ingelheim, Bayer Animal Health, Merck Animal Health, Cargill Inc., Zoetis Inc., Biomin Holding GmbH, Bupo Animal Health, and Elanco Animal Health Incorporated. These market leaders are intensifying R&D investments to develop safe, effective, and regulation-compliant alternatives. Their strategies include diversifying portfolios with plant-based and probiotic ingredients, forging partnerships with feed manufacturers, and expanding operations in emerging markets to capitalize on regional growth potential.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021 - 2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Trump administration tariffs
  • 3.2.1 Impact on trade
    • 3.2.1.1 Trade volume disruptions
    • 3.2.1.2 Retaliatory measures
  • 3.2.2 Impact on the industry
    • 3.2.2.1 Supply-Side impact (Raw Materials)
      • 3.2.2.1.1 Price volatility in key materials
      • 3.2.2.1.2 Supply chain restructuring
      • 3.2.2.1.3 Production cost implications
  • 3.2.3 Demand-Side impact (Selling Price)
    • 3.2.3.1 Price transmission to end markets
    • 3.2.3.2 Market share dynamics
    • 3.2.3.3 Consumer response patterns
  • 3.2.4 Key companies impacted
  • 3.2.5 Strategic industry responses
    • 3.2.5.1 Supply chain reconfiguration
    • 3.2.5.2 Pricing and product strategies
    • 3.2.5.3 Policy engagement
  • 3.2.6 Outlook and future considerations
• 3.3 Trade statistics (HS Code)
  • 3.3.1 Major exporting countries, 2021-2024 (Kilo Tons)
  • 3.3.2 Major importing countries, 2021-2024 (Kilo Tons)

Note: the above trade statistics will be provided for key countries only.

• 3.4 Supplier landscape
• 3.5 Profit margin analysis
• 3.6 Key news & initiatives
• 3.7 Regulatory landscape
• 3.8 Impact forces
  • 3.8.1 Growth drivers
    • 3.8.1.1 Rising global demand for animal-based protein
    • 3.8.1.2 Intensification of livestock farming practices
    • 3.8.1.3 Advancements in animal nutrition and feed additives
    • 3.8.1.4 Expansion of commercial livestock production in emerging markets
  • 3.8.2 Industry pitfalls & challenges
    • 3.8.2.1 Regulatory restrictions on antibiotic-based growth promoters
    • 3.8.2.2 Growing consumer preference for organic and antibiotic-free meat
• 3.9 Growth potential analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021 - 2034 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Antibiotic & non-antibiotic
• 5.3 Probiotic and prebiotic
• 5.4 Organic acid
• 5.5 Phytogenic
• 5.6 Feed enzyme
• 5.7 Hormonal
• 5.8 Others

Chapter 6 Market Estimates & Forecast, By Animal Type, 2021 - 2034 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Poultry
• 6.3 Swine
• 6.4 Livestock
• 6.5 Aquatic animals
• 6.6 Other animals

Chapter 7 Market Estimates & Forecast, By Region, 2021 - 2034 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 UK
  • 7.3.2 Germany
  • 7.3.3 France
  • 7.3.4 Italy
  • 7.3.5 Spain
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 India
  • 7.4.3 Japan
  • 7.4.4 South Korea
  • 7.4.5 Australia
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 MEA
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Bayer Animal Health
• 8.2 Biomin Holding GmbH
• 8.3 Bioniche Animal Health
• 8.4 Boehringer Ingelheim
• 8.5 Bupo Animal Health
• 8.6 Cargill Inc.
• 8.7 DSM
• 8.8 Elanco Animal Health Incorporated
• 8.9 Merck Animal Health
• 8.10 Zoetis Inc.